NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

At the risk of sounding negative, here it goes. Who said that it increases OS by 12 months? Who said that the typical OS for this sub group is only 7-10 months? Les Goldman? NWBO? This wasn't part of the blinded trial and thus these comments by NWBO are a little suspect? People like to see study data backing up what they say.

Pyr said that on a positive note at least everything is on the table now. I disagree. We are still missing enrollment data which will make a huge difference in estimating completion of enrollment and events.

My opinion, long term = good and the short term = bad. With Phase 3 being pushed out until I would guess 2016 we will be left having to raise and dilute. The only thing that can save us IMO is German revenue surprising to the upside and or Direct Phase I data and quick moving Phase II.